Skip to main content

CAPROCK Group, Inc.

SEC CIK
0001610769
Latest filing
Jul 27, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
7,747
Value
$3.00M
% of portfolio
0.1%
Quarters held
20
Since Q1 2021
Holdings of ELV by CAPROCK Group, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267,747$3.00M0.1%+2,228+40.4%AddedHolders
Q1 20265,519$1.62M<0.1%+2,175+65.0%AddedHolders
Q4 20253,344$1.17M<0.1%−1,796−34.9%ReducedHolders
Q3 20255,140$1.64M<0.1%–No prior filingHolders
Q2 2025––––Not filedHolders
Q1 20256,380$2.78M0.1%+989+18.3%AddedHolders
Q4 20245,391$1.99M0.1%+5,391NewHolders
Q3 20240$00.0%−6,318−100.0%Sold outHolders
Q2 20246,318$3.42M0.1%+2,108+50.1%AddedHolders
Q1 20244,210$2.18M0.1%−150−3.4%ReducedHolders
Q4 20234,360$2.06M0.1%−39−0.9%ReducedHolders
Q3 20234,399$1.92M0.1%+65+1.5%AddedHolders
Q2 20234,334$1.93M0.1%−24−0.6%ReducedHolders
Q1 20234,358$2.00M0.2%+284+7.0%AddedHolders
Q4 20224,074$2.09M0.2%+225+5.8%AddedHolders
Q3 20223,849$1.75M0.2%+114+3.1%AddedHolders
Q2 20223,735$1.80M0.2%+233+6.7%AddedHolders
Q1 20223,502$1.72M0.2%+451+14.8%AddedHolders
Q4 20213,051$1.41M0.1%+255+9.1%AddedHolders
Q3 20212,796$1.04M0.1%+41+1.5%AddedHolders
Q2 20212,755$1.05M0.1%+14+0.5%AddedHolders
Q1 20212,741$984.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.